IL13 and multiple sclerosis: A study by Rossi et al.4 provided molecular, physiological and imaging evidence that IL-13 is efficiently involved in the modulation of neuronal integrity and synaptic function in individuals with multiple sclerosis, which suggests that treatments upregulating IL-13 production and release may have not only immunomodulatory effects but also neuroprotective benefits for these patients.